These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 23257155)

  • 1. Lung cancer screening gets risk-specific.
    Peres J
    J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 3. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 4. Save your life: cancer screening is oversold. Know the tests to get--and those to skip.
    Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
    Belpomme D; Irigaray P
    J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for cervical cancer: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2012 Sep; 86(6):555-9. PubMed ID: 23062047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].
    Bratt O; Lundgren R; Ahlgren G
    Lakartidningen; 2012 Sep 12-18; 109(37):1610-2. PubMed ID: 23077769
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for prostate cancer: prostate-specific antigen testing is not effective.
    Hitzeman N; Molina M
    Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
    [No Abstract]   [Full Text] [Related]  

  • 9. Solving the overdiagnosis dilemma.
    Esserman L; Thompson I
    J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer screening rates in individuals with different life expectancies.
    Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
    JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACS releases updated guidelines on cancer screening.
    Lambert M
    Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing mammography's benefits and harms.
    Schmidt C
    J Natl Cancer Inst; 2014 Apr; 106(4):dju103. PubMed ID: 24685934
    [No Abstract]   [Full Text] [Related]  

  • 13. [Responsible cancer screening].
    Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
    Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonizing lung cancer screening guidelines.
    Nicholas J
    J Natl Cancer Inst; 2012 Oct; 104(20):1531-2. PubMed ID: 23044381
    [No Abstract]   [Full Text] [Related]  

  • 15. Can we stop ordering prostate-specific antigen screening tests?
    Katz MH
    JAMA Intern Med; 2013 May; 173(10):847-8. PubMed ID: 23588841
    [No Abstract]   [Full Text] [Related]  

  • 16. PSA-based screening for prostate cancer. Too many adverse effects.
    Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. There is more to life than death.
    Hartzband P; Groopman J
    N Engl J Med; 2012 Sep; 367(11):987-9. PubMed ID: 22970943
    [No Abstract]   [Full Text] [Related]  

  • 18. States renewing attention to prostate cancer.
    Rossiter C
    NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
    [No Abstract]   [Full Text] [Related]  

  • 19. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
    Fontaine PL; Saslow D; King VJ
    Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
    Smith RA; Brooks D; Cokkinides V; Saslow D; Brawley OW
    CA Cancer J Clin; 2013; 63(2):88-105. PubMed ID: 23378235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.